STERIS plc (NYSE:STE) Position Boosted by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP raised its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 5.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 909,521 shares of the medical equipment provider's stock after acquiring an additional 47,637 shares during the period. Dimensional Fund Advisors LP owned approximately 0.92% of STERIS worth $186,961,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the business. Principal Financial Group Inc. lifted its holdings in STERIS by 9.5% in the third quarter. Principal Financial Group Inc. now owns 1,114,224 shares of the medical equipment provider's stock worth $270,230,000 after purchasing an additional 96,336 shares during the period. SkyView Investment Advisors LLC raised its position in shares of STERIS by 1.6% during the 3rd quarter. SkyView Investment Advisors LLC now owns 3,153 shares of the medical equipment provider's stock worth $765,000 after buying an additional 51 shares in the last quarter. World Investment Advisors LLC acquired a new stake in shares of STERIS in the 3rd quarter worth approximately $5,171,000. Wilmington Savings Fund Society FSB bought a new position in shares of STERIS in the third quarter valued at approximately $9,949,000. Finally, Tidal Investments LLC boosted its holdings in shares of STERIS by 21.0% in the third quarter. Tidal Investments LLC now owns 12,650 shares of the medical equipment provider's stock valued at $3,068,000 after acquiring an additional 2,193 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the company. JMP Securities reissued a "market outperform" rating and set a $265.00 target price on shares of STERIS in a report on Thursday, April 10th. Piper Sandler boosted their price objective on STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research note on Monday, February 3rd. Needham & Company LLC reaffirmed a "hold" rating on shares of STERIS in a research note on Monday, April 7th. Finally, Stephens reaffirmed an "overweight" rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $258.75.

STERIS Trading Down 0.6 %

Shares of NYSE:STE traded down $1.35 during midday trading on Friday, reaching $225.00. The company had a trading volume of 368,819 shares, compared to its average volume of 526,071. The company has a fifty day simple moving average of $222.89 and a two-hundred day simple moving average of $218.90. The firm has a market cap of $22.11 billion, a price-to-earnings ratio of 47.77 and a beta of 0.87. STERIS plc has a 1-year low of $200.98 and a 1-year high of $248.24. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.40 and a current ratio of 2.13.

STERIS (NYSE:STE - Get Free Report) last announced its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts predict that STERIS plc will post 9.08 earnings per share for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 1.01%. The ex-dividend date was Thursday, February 20th. STERIS's payout ratio is 48.41%.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.